4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-18-051725
Co-Chief Executive Officer gave up 3,783 shares (to pay taxes)
- Co-Chief Executive Officer acquired 10,938 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
WEST MICHAEL D · Co-Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-09-17 | Exercise or conversion : show line 1 in the form | +10,938 | 897,696 | D | ||
| 2018-09-17 | Shares withheld for taxes : show line 2 in the form | −3,783 | $2.31 | $8,739 | 893,913 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-09-17 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −10,938 | 0 | D |
Loading xslF345X03/doc4.xml…